Cannabis is more effective at preventing and dealing with COVID-19 than hydroxychloroquine

A group of scientists from Canada have identified a minimum of 13 stress of cannabis sativa they think can aid in the prevention and treatment of COVID-19

The President of the United States of America has invested the past few weeks promoting an unsafe drug called hydroxychloroquine as a prophylactic treatment for COVID-19 The president’s knowledge is in reality TELEVISION, not medication. A Number Of studies have actually shown that hydroxychloroquine, a drug created to treat malaria, has unsafe side-effects when utilized to treat coronavirus, including death

The quest for a COVID-19 drug that will both make Donald Trump and his pals in the pharmaceutical industry rich and not kill the people who take it has, up until now, netted no results. Amazing government-sponsored research study out of Canada appears to show a different technique is in order.

Per the group’s research paper:

We have developed over 800 new Cannabis sativa lines and extracts and hypothesized that high-CBD C. sativa extracts might be utilized to regulate ACE2 expression in COVID-19 target tissues. Screening C. sativa extracts using artificial human 3D models of oral, airway, and digestive tract tissues, we recognized 13 high CBD C. sativa extracts that modulate ACE2 gene expression and ACE2 protein levels. Our preliminary data suggest that some C. sativa extract down-regulate serine protease TMPRSS2, another crucial protein needed for SARS-CoV2 entry into host cells.

What this implies is the group has thoroughly developed numerous cannabis stress that have actually been experimentally shown to make it substantially harder for the SARS-CoV2 coronavirus to find a house within the tissue cells it latches onto in order to contaminate us with the COVID-19 illness.

If you must take an untried treatment, I recommend taking Canada’s lead and lawfully imbibing marijuana instead of listening to the Trump administration

[Read: Don’t drink bleach]

A current study led by Harvard Medical School professor Mandeep Mehra which took a look at information from more than 96,000 COVID-19 patients, 15,000 of which had actually been treated with hydroxychloroquine, plainly showed that patients utilizing the drug were at far higher risk for death than those who did not. Per a report from the Washington Post:

For those offered hydroxychloroquine, there was a 34 percent increase in danger of death and a 137 percent increased danger of a severe heart arrhythmias. For those receiving hydroxychloroquine and an antibiotic– the mixed drink backed by Trump– there was a 45 percent increased risk of death and a 411 percent increased risk of serious heart arrhythmias.

Those given chloroquine had a 37 percent increased risk of death and a 256 percent increased threat of major heart arrhythmias. For those taking chloroquine and an antibiotic, there was a 37 percent increased threat of death and a 301 percent increased danger of serious heart arrhythmias.

Donald Trump recently informed reporters and the US public that he ‘d been taking hydroxycholoroquine as a preventative measure to ward off COVID-19

” I desire the people of this nation to feel great. I do not desire them being sick”– Trump claims the White House medical professional approved him taking hydroxychloroquine, which he says he was influenced to start taking since of letters he got

— Aaron Rupar (@atrupar) May 18, 2020

Not only has no one ever passed away from imbibing cannabis, it has clear medical advantages for the prevention and treatment of illness ranging from viral infections to cancer. That, and he may be less of an asshole if he smoked a joint every now and then.

For additional information on the marijuana study, take a look at the full pre-print research paper here And if you would like to know more about why nobody needs to use hydroxycholorquine to avoid or treat COVID-19, please read this important research study

Read next:

A history of sex in video games: When has it crossed the line?

Corona protection

Read our daily coverage on how the tech market is reacting to the coronavirus and subscribe to our weekly newsletter Coronavirus in Context

For ideas and techniques on working remotely, have a look at our Growth Quarters short articles here or follow us on Twitter

Learn more